IL1B and colitis: Enhanced inflammasome activity manifested in mice prior to onset of colitis and the disease could be successfully treated by blockade of NLRP3 inflammasomes or IL-1β signaling demonstrating that symptoms of IL-10 deficiency are mediated by inflammasome perturbation (96, 177, 178).